Geode Capital Management LLC Boosts Stock Holdings in Select Medical Holdings Co. (NYSE:SEM)

Geode Capital Management LLC raised its position in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 2.0% in the third quarter, according to its most recent filing with the SEC. The firm owned 2,442,321 shares of the health services provider's stock after purchasing an additional 46,880 shares during the quarter. Geode Capital Management LLC owned approximately 1.89% of Select Medical worth $85,180,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP boosted its position in shares of Select Medical by 2.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider's stock valued at $157,728,000 after purchasing an additional 95,578 shares in the last quarter. Principal Financial Group Inc. lifted its stake in Select Medical by 6.7% in the third quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider's stock valued at $82,208,000 after buying an additional 147,032 shares during the period. Point72 Asset Management L.P. boosted its holdings in shares of Select Medical by 144.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider's stock worth $71,825,000 after buying an additional 1,216,263 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in shares of Select Medical by 1.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider's stock worth $57,407,000 after buying an additional 24,439 shares during the period. Finally, Victory Capital Management Inc. increased its stake in shares of Select Medical by 0.6% in the 3rd quarter. Victory Capital Management Inc. now owns 1,181,078 shares of the health services provider's stock valued at $41,184,000 after acquiring an additional 7,372 shares in the last quarter. Institutional investors own 89.48% of the company's stock.

Analysts Set New Price Targets

SEM has been the topic of several research analyst reports. Royal Bank of Canada increased their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an "outperform" rating in a research note on Monday, November 4th. StockNews.com raised shares of Select Medical from a "hold" rating to a "buy" rating in a research report on Tuesday, December 3rd. Finally, Benchmark lowered Select Medical from a "buy" rating to a "hold" rating in a research report on Monday, November 25th.

Select Medical Stock Up 4.4 %

SEM traded up $0.80 during trading on Friday, hitting $19.06. 3,832,268 shares of the company's stock were exchanged, compared to its average volume of 701,165. The stock has a market cap of $2.47 billion, a P/E ratio of 8.91, a PEG ratio of 0.39 and a beta of 1.43. The business's 50 day moving average is $29.79 and its two-hundred day moving average is $33.24. Select Medical Holdings Co. has a fifty-two week low of $18.02 and a fifty-two week high of $40.98. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical (NYSE:SEM - Get Free Report) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.07. The business had revenue of $1.76 billion for the quarter, compared to analysts' expectations of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The firm's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter last year, the firm earned $0.46 EPS. As a group, equities analysts expect that Select Medical Holdings Co. will post 1.97 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th were given a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 2.62%. The ex-dividend date of this dividend was Wednesday, November 13th. Select Medical's payout ratio is currently 23.36%.

Insider Buying and Selling at Select Medical

In related news, Director Marilyn B. Tavenner sold 32,000 shares of the stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the sale, the director now directly owns 22,000 shares of the company's stock, valued at approximately $463,980. This trade represents a 59.26 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the business's stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the transaction, the vice president now directly owns 30,356 shares in the company, valued at approximately $605,602.20. This represents a 14.12 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 19.14% of the company's stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.